SecBot SecBot
EFFECT ·Filed Sep 18, 2026

CDT

CDT Equity Inc.
NEUTRAL
Impact 5/10
Horizonimmediate Processed1mo ago SEC9999999995-26-003001
IPO/offering going effective
Actionable Insight • Neutral

Monitor for the pricing announcement and first day of trading, which typically follow effectiveness within 1-2 days. The offering size and price will determine the immediate market reception and potential dilution.

DirectionNeutral
Confidencemedium
Horizonimmediate
Latest settled: T+20d ⚠ clustered
CDT ▼ -94.60% at T+20d
NEUTRAL call -94.60% · α vs SPY -94.80% · entry $0.1740 → $0.009400
Next anchor: T+60d in 7w
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
-11.49%
call -11.49% · α -13.04%
$0.1540
settled 5w ago
T+5d
-54.02%
call -54.02% · α -55.29%
$0.0800
settled 5w ago
T+20d
-94.60%
call -94.60% · α -94.80%
$0.009400
settled 12d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

CDT Equity Inc.'s S-1 registration statement (File No. 333-298808) became effective on September 17, 2026, clearing the way for the company's initial public offering. The effectiveness follows the S-1 filed 9 days ago and typically precedes pricing by 1-2 days, meaning the IPO is imminent. The company will now be able to sell shares to the public, with the offering size and pricing terms to be determined.

Key Facts

  • S-1 registration became effective on September 17, 2026
  • IPO is now cleared to proceed; pricing expected within 1-2 days
  • Offering size and price per share are not disclosed in the EFFECT filing
  • Company is a pharmaceutical preparations firm (SIC 2834), formerly Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp.

Financial Impact

IPO proceeds to be determined; no dollar amounts provided in the EFFECT notice

dilutioncash

Risk Factors

  • IPO pricing and demand are unknown; weak pricing could signal poor investor sentiment
  • Post-IPO lockup expiration and selling stockholder resales (per prior S-1) may create overhang
  • Company has a history of reverse stock splits and convertible note financing, indicating prior capital structure complexity

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-003001
Document: 9999999995-26-003001-index.html9999999995-26-003001
Document: 9999999995-26-003001.txt9999999995-26-003001
23 reports for CDT
Performance horizon
89% Hit rate @ T+20 8 of 9 directional calls Went positive at some point 13 of 13 best @ T+60▲ +99.88%Jul 31, 2026
Filters
Rows
Reports for CDT, sortable and filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 3/10
$0.0837awaiting T+20awaiting T+20$0.0800 (−4.42%)
Oct 27, 2026
today
DEF 14A
BEARISH ★ 6/10
$0.0890awaiting T+20awaiting T+20$0.0800 (+10.11%)
Oct 27, 2026
today
SC 13D/A
NEUTRAL ★ 4/10
$0.0890awaiting T+20awaiting T+20$0.0800 (−10.11%)
Oct 27, 2026
today
3
NEUTRAL ★ 2/10
$0.0819awaiting T+20awaiting T+20$0.0800 (−2.32%)
Oct 27, 2026
today
8-K
BEARISH ★ 6/10
$0.0982awaiting T+20awaiting T+20$0.0800 (+18.53%)
Oct 13, 2026
14d ago
8-K
BEARISH ★ 7/10
$0.4500awaiting T+20awaiting T+20$0.0800 (+82.22%)
Oct 8, 2026
19d ago
SC 13G/A
BEARISH ★ 5/10
$0.7180awaiting T+20awaiting T+20$0.0800 (+88.86%)
Oct 7, 2026
20d ago
SC 13G
NEUTRAL ★ 4/10
$0.8000awaiting T+20awaiting T+20$0.0800 (−90.00%)
Oct 7, 2026
20d ago
SC 13G/A
BEARISH ★ 5/10
$0.8000awaiting T+20awaiting T+20$0.0800 (+90.00%)
Oct 7, 2026
20d ago
SC 13G/A
BEARISH ★ 5/10
$0.8000awaiting T+20awaiting T+20$0.0800 (+90.00%)
Showing 10 of 23

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026